Pharmacogenetics of anxiety disorders
Author:
- 1 May 2020
- journal article
- review article
- Published by Elsevier in Neuroscience Letters
- Vol. 726, 134443
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Genetic Polymorphisms in Monoamine Systems and Outcome of Cognitive Behavior Therapy for Social Anxiety DisorderPLOS ONE, 2013
- Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysisFrontiers in Integrative Neuroscience, 2013
- Neurotrophic gene polymorphisms and response to psychological therapyTranslational Psychiatry, 2012
- Therapygenetics: the 5HTTLPR and response to psychological therapyMolecular Psychiatry, 2011
- Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing miceLearning & Memory, 2011
- The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorderBMC Psychiatry, 2010
- Central serotonin transporter levels are associated with stress hormone response and anxietyPsychopharmacology, 2010
- Association Study between 5-HT1A Receptor Gene C(-1019)G Polymorphism and Panic Disorder in a Korean PopulationPsychiatry Investigation, 2010
- Risk and resilience: Genetic and environmental influences on development of the stress responseDepression and Anxiety, 2009
- Association of serotonin-1A and 2A receptor promoter polymorphisms with depressive symptoms and functional recovery in elderly persons after hip fractureJournal of Affective Disorders, 2008